Amicus Therapeutics Inc logo

Amicus Therapeutics Inc

$ 10.85 -0.06 (-0.55%) 04:00 PM EST
P/E:
At Loss
P/B:
17.57
Market Cap:
$ 3.04B
Enterprise V:
$ 3.12B
Volume:
2.11M
Avg Vol (2M):
2.87M
Also Trade In:
Volume:
2.11M
Market Cap $:
3.04B
PE Ratio:
At Loss
Avg Vol (2-Month):
2.87M
Enterprise Value $:
3.12B
PB Ratio:
17.57
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio.

Financials (Next Earnings Date:2022-11-09 Est.)

FOLD's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:FOLD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 321.145
EPS (TTM) ($) -0.99
Beta 0.63
Volatility % 62.12
14-Day RSI 51.45
14-Day ATR ($) 0.51793
20-Day SMA ($) 10.7065
12-1 Month Momentum % 16.7
52-Week Range ($) 5.91 - 12.96
Shares Outstanding (Mil) 280.5

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Amicus Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Amicus Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.